- Previous Close
4.560 - Open
4.510 - Bid 4.610 x --
- Ask 4.610 x --
- Day's Range
4.350 - 4.780 - 52 Week Range
4.320 - 7.380 - Volume
3,746,200 - Avg. Volume
3,767,800 - Market Cap (intraday)
3.534B - Beta (5Y Monthly) -0.48
- PE Ratio (TTM)
-- - EPS (TTM)
-0.540 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Sipai Health Technology Co., Ltd. operates as a medical technology and health management company in the People's Republic of China. The company operates through three segments: Specialty Pharmacy Business, Physician Research Assistance Business, and Health Insurance Services Business. The Specialty Pharmacy Business segment operates specialty pharmacy stores; and distributes pharmaceutical products to pharmaceutical companies and other distributors. The Physician Research Assistance Business segment offers pharmaceutical companies and other clinical trial institutions site management organization services, including site feasibility, site initiation, patient recruitment, patient management, data entry and document management, on-site drug management and bio-sample management, site closure, and others; and services for image management in clinical trials. The Health Insurance Services Business segment provides insurance brokerage services to insurance companies; and health management services to insurance carriers and enterprise clients. The company was founded in 2014 and is headquartered in Putuo, the People's Republic of China.
www.medbankshealthtech.com3,247
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 0314.HK
View MorePerformance Overview: 0314.HK
Trailing total returns as of 4/8/2025, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 0314.HK
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 0314.HK
View MoreValuation Measures
Market Cap
3.47B
Enterprise Value
2.53B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.60
Price/Book (mrq)
2.65
Enterprise Value/Revenue
0.52
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-7.09%
Return on Assets (ttm)
-8.16%
Return on Equity (ttm)
-25.55%
Revenue (ttm)
4.57B
Net Income Avi to Common (ttm)
-323.74M
Diluted EPS (ttm)
-0.540
Balance Sheet and Cash Flow
Total Cash (mrq)
919.77M
Total Debt/Equity (mrq)
3.79%
Levered Free Cash Flow (ttm)
--